Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI

Key facts

Where
Toronto, CanadaSee the site

Where in Canada

  • Lyndhurst Centre, KITE - TRI UHNToronto, CanadaContact: Mitsue Aibe, MDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
University Health Network, Toronto
Trial code
NCT04007380
Record updated
11 December 2024
Original description
This clinical trial will examine the efficacy of continuous positive airway pressure (CPAP) therapy in improving psychosocial, neurocognitive and behavioral consequences of moderate-to-severe sleep-related breathing disorders (SRBDs) in people living with spinal cord injury (SCI).Read full original descriptionShow less

Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing in Spinal Cord Injured People

This clinical trial will examine the efficacy of continuous positive airway pressure (CPAP) therapy in improving psychosocial, neurocognitive and behavioral consequences of moderate-to-severe sleep-related breathing disorders (SRBDs) in people living with spinal cord injury (SCI).

Inclusion: English-speaking adults 18 years of age or older; Have traumatic cervical/thoracic (injury level at C5 to T10), severe or moderate (AIS A, B, or C) SCI who were not diagnosed with a sleep disorder prior to the injury; At least 2 months after injury; Clinical warning symptoms and/or signs for SRBDs.

Exclusion: Concomitant diseases of the central nervous system; Patients with a non-traumatic spinal cord disease at risk for neurologic progression; Psychiatric disorders that may prevent the participant to be compliant to the study protocol requirements; Neuromuscular diseases; History of primary hypersomnia; Active infection; Kidney failure; Epilepsy; Chronic fatigue syndrome; Preinjury chronic pain; Current substance misuse; Hypothyroidism; Moderate or severe iron deficiency anemia; Vitamin B12 deficiency.

ClinicalTrials.gov NCT04007380